Get started
Award

C12292/A11174

Funded outputs count: 99
Funder award ID: C12292/A11174
OpenAlex ID: G7557895011
Circulating Inflammatory Markers and Mammographic Density Phenotypes: a Mendelian Randomization Analysis
2026 · Austin Hammermeister Suger, Tabitha A. Harrison, et al. · medRxiv
Investigating the repurposing potential of immune checkpoint inhibition for cancer treatment using Mendelian randomisation
2026 · Tessa Bate, Mei Dong, et al. · Research Square
PDF
PRANA: A Deep Learning Method for Adapting Polygenic Risk Scores to Diverse Ethnic Groups
2026 · Hagai Levi, Qin Wang, et al. · medRxiv
PDF
Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study
2026 · Jason L. Vassy, Anna M. Dornisch, et al. · Nature Cancer · 8
Identifying proteomic risk factors for overall, aggressive, and early onset prostate cancer using Mendelian Randomisation and tumour spatial transcriptomics
2024 · Trishna A. Desai, Åsa K. Hedman, et al. · EBioMedicine · 27
Phenome-wide Mendelian randomisation analysis of 378,142 cases reveals risk factors for eight common cancers
2024 · Molly Went, Amit Sud, et al. · Nature Communications · 28
PDF
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study
2024 · Clarke, C.L., Anton-Culver, H., et al. · Kölner Universitäts PublikationsServer (Universität zu Köln)
PDF
Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis
2024 · Castelao, J.E., Geisler, J., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment
2024 · Koutros, S., Janni, W., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
A network analysis to identify mediators of germline-driven differences in breast cancer prognosis
2024 · Manoukian, S., Ramachandran, D., et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk
2024 · Daniel R. Barnes, Jonathan P. Tyrer, et al. · medRxiv · 3
PDF
Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants
2023 · Anqi Wang, Jiayi Shen, et al. · Nature Genetics · 146
Unravelling the Role of Iroquois Homeobox 4 and its Interplay with Androgen Receptor in Prostate Cancer
2023 · Jyotsna Batra, Janaththani Panchadsaram, et al. · Research Square · 1
PDF
A Likelihood Ratio Approach for Utilizing Case-Control Data in the Clinical Classification of Rare Sequence Variants: Application to BRCA1 and BRCA2
2023 · Maria Zanti, Denise G. O'Mahony, et al. · Human Mutation · 6
Identification of blood protein biomarkers associated with prostate cancer risk using genetic prediction models: analysis of over 140,000 subjects
2023 · Hua Zhong, Jingjing Zhu, et al. · Human Molecular Genetics · 14
PDF
African-specific improvement of a polygenic hazard score for age at diagnosis of prostate cancer
2023 · Kote-Jarai, Z., The PRACTICAL Consortium, et al. · Carolina Digital Repository (University of North Carolina at Chapel Hill)
PDF
Germline Genetic Variants Associated with Somatic TMPRSS2:ERG Fusion Status in Prostate Cancer: A Genome-Wide Association Study
2023 · Chaoran Ma, Xiaoyu Wang, et al. · Cancer Epidemiology Biomarkers & Prevention · 3
PDF
A genome-wide gene-environment interaction study of breast cancer risk for women of European ancestry
2023 · Pooja Middha, Xiaoliang Wang, et al. · Breast Cancer Research · 14
PDF
Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel
2023 · Hagai Levi, Shai Carmi, et al. · Journal of Medical Genetics · 4
PDF
Association of the CHEK2 c. 1100delC variant, radiotherapy, and systemic treatment with contralateral breast cancer risk and breast cancer‐specific survival
2023 · Anna Morra, Maartje A. C. Schreurs, et al. · Cancer Medicine · 11
PDF
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2
2023 · Denise G. O’Mahony, Susan J. Ramus, et al. · British Journal of Cancer · 21
PDF
Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions
2023 · Sara Lindström, Lu Wang, et al. · JNCI Journal of the National Cancer Institute · 31
PDF
Associations of a Breast Cancer Polygenic Risk Score With Tumor Characteristics and Survival
2023 · Josephine M.N. Lopes Cardozo, Irene L. Andrulis, et al. · Journal of Clinical Oncology · 29
PDF
Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study
2022 · Suzanne C Dixon-Suen, Sarah J Lewis, et al. · British Journal of Sports Medicine · 88
Genome-wide interaction analysis of menopausal hormone therapy use and breast cancer risk among 62,370 women
2022 · Xiaoliang Wang, Pooja Middha Kapoor, et al. · Scientific Reports · 6
PDF
Year
Topic